Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome

Inserm, Délégation Paris 7, Université Paris Cité, Hôpital Bichat-Claude-Bernard, University of Colorado Denver, Royal Brompton Hospital, Lung Institute, State University of New York, SUNY Downstate Health Sciences University, Brigham and Women's Hospital, Harvard University, University of Alabama at Birmingham, Instituto Cardiovascular de Rosario, Sanofi (United States), St. Michael's Hospital, University of Alberta, University of Toronto, Canadian VIGOUR Centre, Center for Clinical Research (United States), Stanford University, Leiden University Medical Center, Regeneron (United States), Clinical Research Institute, Duke Medical Center, Duke University, Auckland City Hospital, Goethe University Frankfurt